Hormonal
SGLT2 inhibitors lower blood pressure primarily through early osmotic diuresis and volume contraction, with sustained effects driven by reduced arterial stiffness and improved endothelial function.
If you have heart failure or diabetes, SGLT2 inhibitors (like Jardiance or Farxiga) will likely lower your blood pressure slightly, but this is a bonus, not the main reason for taking them. The benefit comes from reducing fluid volume and improving artery health, not just sugar control.
SGLT2is exert antihypertensive effects through an interplay of hemodynamic and vascular mechanisms... The resultant BP decline is typically observed within days of therapy initiation... SGLT2is are proven to decrease arterial stiffness... These improvements in arterial compliance complement the early hemodynamic effects driven by natriuresis and volume contraction.
Why this rating
Supported by multiple trial types (CVOTs, HF trials) and real-world data, though dedicated BP trials are noted as lacking.
Source
Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data
Andrej Belančić et al. · British Journal of Clinical Pharmacology · 2025
DOI 10.1002/bcp.70378
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →